Skip to content
healthcare.dev

buprenorphine transdermal system

NDC 47781-408, buprenorphine, patch, extended release, from Alvogen Inc..

Product NDC
47781-408
Status
Listed
Labeler
Alvogen Inc.
Dosage form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207490
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47781-408 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE20 ug/h

Pharmacologic classes

Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
47781-408-04477810408044 POUCH in 1 CARTON (47781-408-04) / 1 PATCH in 1 POUCH (47781-408-11) / 168 h in 1 PATCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/315284b8-32ab-d34a-ea02-f501c6131bcc
  • NADAC price for package 47781040804

    GET /v1/drugs/nadac/47781040804

Use it

Look up 47781-408 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47781-408 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47781-408. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.